PRA Health Sciences (PRAH) executive Shannon sold 231,348 shares for $38.8M at an average $167.61 under a 10b5-1 plan
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Colin Shannon (executive at PRA Health Sciences, Inc., PRAH) reported that they sold 231,348 shares for $38.8M at an average $167.61, and acquired 221,031 shares at $11.73 between Jun 15, 2021 and Jun 16, 2021. After these transactions the filing shows 54,626 shares held directly.
- Reporting person
- Shannon Colin
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 15, 2021 | Exercise or conversion of a derivative (M) | Common Stock | +132,986 | $11.73 | $1.56M | 197,929 direct |
| Jun 15, 2021 | Open-market sale (S) | Common Stock1, 2, 3 | -143,303 | avg $168.30 | $24.1M | 54,626 direct |
| Jun 16, 2021 | Exercise or conversion of a derivative (M) | Common Stock | +88,045 | $11.73 | $1.03M | 142,671 direct |
| Jun 16, 2021 | Open-market sale (S) | Common Stock1, 4, 5 | -88,045 | avg $166.49 | $14.7M | 54,626 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 15, 2021 | Exercise or conversion of a derivative (M) | Stock Option (Right to Buy)On 132,986 Common Stock | -132,986 | - | - | 16,242 direct |
| Jun 16, 2021 | Exercise or conversion of a derivative (M) | Stock Option (Right to Buy)On 88,045 Common Stock | -88,045 | - | - | 77,425 direct |
Holdings before and after
- Common Stock: 64,943 to 54,626 direct
- Stock Option (Right to Buy): 149,228 to 77,425 direct
Footnotes from the filing
- 1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.685 to 168.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) to this Form 4.
- 3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.68 to 168.87, inclusive.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Shannon report in this PRAH Form 4?
Colin Shannon (executive at PRA Health Sciences, Inc., PRAH) reported that they sold 231,348 shares for $38.8M at an average $167.61, and acquired 221,031 shares at $11.73 between Jun 15, 2021 and Jun 16, 2021. After these transactions the filing shows 54,626 shares held directly.
How many PRAH shares does Shannon hold after this filing?
The filing shows 54,626 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this PRAH insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for PRAH
Earlier insider filings at PRAH
- Jun 3, 2021SEC Form 4: Young Matthew P. was granted 250 units of Common Stock, increasing direct ownership by 4% to 7,127 units
- Jun 3, 2021SEC Form 4: SHANNON COLIN was granted 14,486 units of Common Stock and sold $1,102,812 worth of Common Stock (6,470 units at $170.45), increasing direct ownership by 14% to 64,943 units (withholding obligation)
- Jun 3, 2021SEC Form 4: Stettin Glen D. was granted 250 units of Common Stock, increasing direct ownership by 31% to 1,049 units
- Jun 3, 2021SEC Form 4: Bonello Michael J. was granted 4,823 units of Common Stock and sold $372,263 worth of Common Stock (2,184 units at $170.45), increasing direct ownership by 14% to 21,867 units (tax withholding)
- Jun 3, 2021SEC Form 4: MOMTAZEE JAMES C was granted 330 units of Common Stock, increasing direct ownership by 10% to 3,521 units
Keep researching PRAH
- PRAH insider tradesEvery buy and sale reported by PRA Health Sciences, Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
PRAH
PRA Health Sciences, Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Listed since
- 2014
Get push alerts for PRAH
Full PRAH profile on Quantisnow Follow PRAH and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time